DY
OGN icon

Dowling & Yahnke’s Organon & Co OGN Stock Holding History

Dowling & Yahnke’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-6,309
Closed -$213K – 383
2022
Q2 		$213K Sell
6,309
-301
-5% -$10.5K 0.01% 345
2022
Q1 		$231K Sell
6,610
-593
-8% -$20.3K 0.01% 346
2021
Q4 		$219K Sell
7,203
-1,068
-13% -$34.8K 0.01% 360
2021
Q3 		$271K Sell
8,271
-1,994
-19% -$63.8K 0.02% 322
2021
Q2 		$311K Buy
+10,265
New +$338K 0.02% 301

Other funds holding OGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Mawer Investment Management
Mawer Investment Management Calgary, Alberta, Canada $14.7B AUM 12.5% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Dowling & Yahnke's OGN Position: Q3 2022 in Review

Dowling & Yahnke sold out of Organon & Co (OGN) in Q3 2022, closing a stake of 6,309 shares — an estimated $213K sold.

Dowling & Yahnke first reported a position in OGN in Q2 2021 and held it in 5 quarters. The position peaked at $311K in Q2 2021. 791 funds tracked by Wall St. Rank hold OGN as of Q3 2022.

  • Dowling & Yahnke reported no remaining Organon & Co position as of Q3 2022 after selling out during the quarter.
  • Dowling & Yahnke sold 6,309 Organon & Co shares in Q3 2022, an estimated $213K.
  • Dowling & Yahnke first reported a position in Organon & Co in Q2 2021 and held it in 5 quarters.
  • Dowling & Yahnke's Organon & Co position peaked at $311K in Q2 2021.
  • 791 funds tracked by Wall St. Rank held Organon & Co as of Q3 2022.

Based on Dowling & Yahnke's 13F filing for Q3 2022, filed 3 Nov 2022.